PREVALANCE AND CLINICOPATHOLOGICAL ASSESSMENT OF INFLAMMATORY BREAST CANCER PATIENTS DIAGNOSED BETWEEN 2000 AND 2008

dc.contributor.authorKaraca, B.
dc.contributor.authorTunali, D.
dc.contributor.authorGorumlu, G.
dc.contributor.authorDegirmenci, M.
dc.contributor.authorGoker, E.
dc.date.accessioned2019-10-27T20:51:58Z
dc.date.available2019-10-27T20:51:58Z
dc.date.issued2009
dc.departmentEge Üniversitesien_US
dc.descriptionIMPAKT Breast Cancer Conference 2009 -- MAY 07-09, 2009 -- Brussels, BELGIUMen_US
dc.description.sponsorshipGlaxoSmithKline, IPSOGEN, ROCHE, AMGEN, Merck Seromo, Genom, Pfizer Oncol, Bristol Myers Squibb, Onyx, Schering-Plough, Wyethen_US
dc.identifier.endpage58en_US
dc.identifier.issn0923-7534
dc.identifier.startpage58en_US
dc.identifier.urihttps://hdl.handle.net/11454/43174
dc.identifier.volume20en_US
dc.identifier.wosWOS:000266498000174en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofAnnals of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePREVALANCE AND CLINICOPATHOLOGICAL ASSESSMENT OF INFLAMMATORY BREAST CANCER PATIENTS DIAGNOSED BETWEEN 2000 AND 2008en_US
dc.typeConference Objecten_US

Dosyalar